Co-founder Hayes departs in EiRx shake-up
EiRx, which is developing a treatment for colorectal cancer, also announced a shake-up of its other top management team yesterday.
The company said the departure of Dr Hayes was part its plan for a new company structure to focus on growing revenues.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





